GO:0000775 | chromosome, centromeric region | 6.35e-05 | 6.20e-01 | 5.233 | 3 | 6 | 41 |
GO:0045120 | pronucleus | 1.95e-04 | 1.00e+00 | 6.546 | 2 | 3 | 11 |
GO:0034080 | CENP-A containing nucleosome assembly | 6.67e-04 | 1.00e+00 | 5.684 | 2 | 2 | 20 |
GO:0005654 | nucleoplasm | 8.77e-04 | 1.00e+00 | 2.038 | 7 | 68 | 876 |
GO:0014013 | regulation of gliogenesis | 1.95e-03 | 1.00e+00 | 9.005 | 1 | 1 | 1 |
GO:0004832 | valine-tRNA ligase activity | 1.95e-03 | 1.00e+00 | 9.005 | 1 | 1 | 1 |
GO:0045605 | negative regulation of epidermal cell differentiation | 1.95e-03 | 1.00e+00 | 9.005 | 1 | 1 | 1 |
GO:0046605 | regulation of centrosome cycle | 1.95e-03 | 1.00e+00 | 9.005 | 1 | 1 | 1 |
GO:0000939 | condensed chromosome inner kinetochore | 1.95e-03 | 1.00e+00 | 9.005 | 1 | 1 | 1 |
GO:0006438 | valyl-tRNA aminoacylation | 1.95e-03 | 1.00e+00 | 9.005 | 1 | 1 | 1 |
GO:0090233 | negative regulation of spindle checkpoint | 1.95e-03 | 1.00e+00 | 9.005 | 1 | 1 | 1 |
GO:0032436 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process | 2.42e-03 | 1.00e+00 | 4.758 | 2 | 4 | 38 |
GO:0048511 | rhythmic process | 2.42e-03 | 1.00e+00 | 4.758 | 2 | 5 | 38 |
GO:0000278 | mitotic cell cycle | 2.77e-03 | 1.00e+00 | 2.711 | 4 | 28 | 314 |
GO:0045892 | negative regulation of transcription, DNA-templated | 2.87e-03 | 1.00e+00 | 2.697 | 4 | 17 | 317 |
GO:0048742 | regulation of skeletal muscle fiber development | 3.89e-03 | 1.00e+00 | 8.005 | 1 | 1 | 2 |
GO:1900195 | positive regulation of oocyte maturation | 3.89e-03 | 1.00e+00 | 8.005 | 1 | 1 | 2 |
GO:0043146 | spindle stabilization | 3.89e-03 | 1.00e+00 | 8.005 | 1 | 1 | 2 |
GO:0007057 | spindle assembly involved in female meiosis I | 3.89e-03 | 1.00e+00 | 8.005 | 1 | 1 | 2 |
GO:0004647 | phosphoserine phosphatase activity | 3.89e-03 | 1.00e+00 | 8.005 | 1 | 1 | 2 |
GO:0005846 | nuclear cap binding complex | 3.89e-03 | 1.00e+00 | 8.005 | 1 | 1 | 2 |
GO:0002176 | male germ cell proliferation | 3.89e-03 | 1.00e+00 | 8.005 | 1 | 1 | 2 |
GO:0072687 | meiotic spindle | 3.89e-03 | 1.00e+00 | 8.005 | 1 | 1 | 2 |
GO:2000781 | positive regulation of double-strand break repair | 3.89e-03 | 1.00e+00 | 8.005 | 1 | 1 | 2 |
GO:0007100 | mitotic centrosome separation | 3.89e-03 | 1.00e+00 | 8.005 | 1 | 2 | 2 |
GO:0006334 | nucleosome assembly | 4.32e-03 | 1.00e+00 | 4.333 | 2 | 4 | 51 |
GO:0004842 | ubiquitin-protein transferase activity | 4.73e-03 | 1.00e+00 | 3.107 | 3 | 17 | 179 |
GO:0005850 | eukaryotic translation initiation factor 2 complex | 5.83e-03 | 1.00e+00 | 7.421 | 1 | 2 | 3 |
GO:0051154 | negative regulation of striated muscle cell differentiation | 5.83e-03 | 1.00e+00 | 7.421 | 1 | 1 | 3 |
GO:0036123 | histone H3-K9 dimethylation | 5.83e-03 | 1.00e+00 | 7.421 | 1 | 1 | 3 |
GO:0000778 | condensed nuclear chromosome kinetochore | 5.83e-03 | 1.00e+00 | 7.421 | 1 | 2 | 3 |
GO:0035404 | histone-serine phosphorylation | 5.83e-03 | 1.00e+00 | 7.421 | 1 | 1 | 3 |
GO:0070314 | G1 to G0 transition | 5.83e-03 | 1.00e+00 | 7.421 | 1 | 1 | 3 |
GO:0042585 | germinal vesicle | 5.83e-03 | 1.00e+00 | 7.421 | 1 | 2 | 3 |
GO:0006563 | L-serine metabolic process | 5.83e-03 | 1.00e+00 | 7.421 | 1 | 1 | 3 |
GO:0071459 | protein localization to chromosome, centromeric region | 5.83e-03 | 1.00e+00 | 7.421 | 1 | 1 | 3 |
GO:0046976 | histone methyltransferase activity (H3-K27 specific) | 7.76e-03 | 1.00e+00 | 7.005 | 1 | 1 | 4 |
GO:0071539 | protein localization to centrosome | 7.76e-03 | 1.00e+00 | 7.005 | 1 | 1 | 4 |
GO:0045292 | mRNA cis splicing, via spliceosome | 7.76e-03 | 1.00e+00 | 7.005 | 1 | 1 | 4 |
GO:1990138 | neuron projection extension | 7.76e-03 | 1.00e+00 | 7.005 | 1 | 1 | 4 |
GO:0031442 | positive regulation of mRNA 3'-end processing | 7.76e-03 | 1.00e+00 | 7.005 | 1 | 1 | 4 |
GO:0006290 | pyrimidine dimer repair | 7.76e-03 | 1.00e+00 | 7.005 | 1 | 2 | 4 |
GO:0036124 | histone H3-K9 trimethylation | 7.76e-03 | 1.00e+00 | 7.005 | 1 | 2 | 4 |
GO:0006333 | chromatin assembly or disassembly | 7.76e-03 | 1.00e+00 | 7.005 | 1 | 1 | 4 |
GO:0006564 | L-serine biosynthetic process | 7.76e-03 | 1.00e+00 | 7.005 | 1 | 1 | 4 |
GO:0070734 | histone H3-K27 methylation | 7.76e-03 | 1.00e+00 | 7.005 | 1 | 1 | 4 |
GO:0071156 | regulation of cell cycle arrest | 7.76e-03 | 1.00e+00 | 7.005 | 1 | 2 | 4 |
GO:0035174 | histone serine kinase activity | 7.76e-03 | 1.00e+00 | 7.005 | 1 | 1 | 4 |
GO:0090344 | negative regulation of cell aging | 9.69e-03 | 1.00e+00 | 6.684 | 1 | 1 | 5 |
GO:0021695 | cerebellar cortex development | 9.69e-03 | 1.00e+00 | 6.684 | 1 | 1 | 5 |
GO:0071168 | protein localization to chromatin | 9.69e-03 | 1.00e+00 | 6.684 | 1 | 2 | 5 |
GO:0006282 | regulation of DNA repair | 9.69e-03 | 1.00e+00 | 6.684 | 1 | 2 | 5 |
GO:0032873 | negative regulation of stress-activated MAPK cascade | 9.69e-03 | 1.00e+00 | 6.684 | 1 | 1 | 5 |
GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway | 9.69e-03 | 1.00e+00 | 6.684 | 1 | 1 | 5 |
GO:0002161 | aminoacyl-tRNA editing activity | 9.69e-03 | 1.00e+00 | 6.684 | 1 | 1 | 5 |
GO:0043203 | axon hillock | 9.69e-03 | 1.00e+00 | 6.684 | 1 | 1 | 5 |
GO:0031616 | spindle pole centrosome | 9.69e-03 | 1.00e+00 | 6.684 | 1 | 1 | 5 |
GO:0000122 | negative regulation of transcription from RNA polymerase II promoter | 1.04e-02 | 1.00e+00 | 2.173 | 4 | 29 | 456 |
GO:0042127 | regulation of cell proliferation | 1.04e-02 | 1.00e+00 | 3.684 | 2 | 4 | 80 |
GO:0003723 | RNA binding | 1.15e-02 | 1.00e+00 | 2.642 | 3 | 22 | 247 |
GO:0050847 | progesterone receptor signaling pathway | 1.16e-02 | 1.00e+00 | 6.421 | 1 | 2 | 6 |
GO:0042754 | negative regulation of circadian rhythm | 1.16e-02 | 1.00e+00 | 6.421 | 1 | 2 | 6 |
GO:0046974 | histone methyltransferase activity (H3-K9 specific) | 1.16e-02 | 1.00e+00 | 6.421 | 1 | 1 | 6 |
GO:0046578 | regulation of Ras protein signal transduction | 1.16e-02 | 1.00e+00 | 6.421 | 1 | 1 | 6 |
GO:0003682 | chromatin binding | 1.21e-02 | 1.00e+00 | 2.613 | 3 | 15 | 252 |
GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter | 1.35e-02 | 1.00e+00 | 6.198 | 1 | 1 | 7 |
GO:0002199 | zona pellucida receptor complex | 1.35e-02 | 1.00e+00 | 6.198 | 1 | 4 | 7 |
GO:0042054 | histone methyltransferase activity | 1.35e-02 | 1.00e+00 | 6.198 | 1 | 1 | 7 |
GO:0007140 | male meiosis | 1.35e-02 | 1.00e+00 | 6.198 | 1 | 1 | 7 |
GO:0000731 | DNA synthesis involved in DNA repair | 1.35e-02 | 1.00e+00 | 6.198 | 1 | 1 | 7 |
GO:0006301 | postreplication repair | 1.35e-02 | 1.00e+00 | 6.198 | 1 | 2 | 7 |
GO:0051642 | centrosome localization | 1.35e-02 | 1.00e+00 | 6.198 | 1 | 1 | 7 |
GO:0000339 | RNA cap binding | 1.35e-02 | 1.00e+00 | 6.198 | 1 | 1 | 7 |
GO:0000780 | condensed nuclear chromosome, centromeric region | 1.35e-02 | 1.00e+00 | 6.198 | 1 | 1 | 7 |
GO:0005832 | chaperonin-containing T-complex | 1.35e-02 | 1.00e+00 | 6.198 | 1 | 4 | 7 |
GO:0045814 | negative regulation of gene expression, epigenetic | 1.35e-02 | 1.00e+00 | 6.198 | 1 | 1 | 7 |
GO:0051382 | kinetochore assembly | 1.35e-02 | 1.00e+00 | 6.198 | 1 | 2 | 7 |
GO:0005829 | cytosol | 1.38e-02 | 1.00e+00 | 1.202 | 8 | 88 | 1787 |
GO:0000086 | G2/M transition of mitotic cell cycle | 1.50e-02 | 1.00e+00 | 3.406 | 2 | 7 | 97 |
GO:0005845 | mRNA cap binding complex | 1.55e-02 | 1.00e+00 | 6.005 | 1 | 1 | 8 |
GO:0006450 | regulation of translational fidelity | 1.55e-02 | 1.00e+00 | 6.005 | 1 | 1 | 8 |
GO:0010944 | negative regulation of transcription by competitive promoter binding | 1.55e-02 | 1.00e+00 | 6.005 | 1 | 1 | 8 |
GO:0010388 | cullin deneddylation | 1.55e-02 | 1.00e+00 | 6.005 | 1 | 4 | 8 |
GO:0009948 | anterior/posterior axis specification | 1.55e-02 | 1.00e+00 | 6.005 | 1 | 1 | 8 |
GO:0010225 | response to UV-C | 1.74e-02 | 1.00e+00 | 5.836 | 1 | 2 | 9 |
GO:0006379 | mRNA cleavage | 1.74e-02 | 1.00e+00 | 5.836 | 1 | 2 | 9 |
GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process | 1.74e-02 | 1.00e+00 | 5.836 | 1 | 2 | 9 |
GO:0071354 | cellular response to interleukin-6 | 1.74e-02 | 1.00e+00 | 5.836 | 1 | 1 | 9 |
GO:0048387 | negative regulation of retinoic acid receptor signaling pathway | 1.74e-02 | 1.00e+00 | 5.836 | 1 | 2 | 9 |
GO:0032039 | integrator complex | 1.74e-02 | 1.00e+00 | 5.836 | 1 | 1 | 9 |
GO:0005515 | protein binding | 1.92e-02 | 1.00e+00 | 0.696 | 13 | 198 | 4124 |
GO:0005095 | GTPase inhibitor activity | 1.93e-02 | 1.00e+00 | 5.684 | 1 | 1 | 10 |
GO:0007049 | cell cycle | 2.06e-02 | 1.00e+00 | 3.160 | 2 | 8 | 115 |
GO:0060766 | negative regulation of androgen receptor signaling pathway | 2.12e-02 | 1.00e+00 | 5.546 | 1 | 4 | 11 |
GO:0008652 | cellular amino acid biosynthetic process | 2.12e-02 | 1.00e+00 | 5.546 | 1 | 2 | 11 |
GO:0008334 | histone mRNA metabolic process | 2.12e-02 | 1.00e+00 | 5.546 | 1 | 1 | 11 |
GO:0000132 | establishment of mitotic spindle orientation | 2.31e-02 | 1.00e+00 | 5.421 | 1 | 2 | 12 |
GO:0035098 | ESC/E(Z) complex | 2.50e-02 | 1.00e+00 | 5.305 | 1 | 1 | 13 |
GO:2000377 | regulation of reactive oxygen species metabolic process | 2.50e-02 | 1.00e+00 | 5.305 | 1 | 1 | 13 |
GO:0006978 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator | 2.69e-02 | 1.00e+00 | 5.198 | 1 | 1 | 14 |
GO:0016575 | histone deacetylation | 2.69e-02 | 1.00e+00 | 5.198 | 1 | 2 | 14 |
GO:2000134 | negative regulation of G1/S transition of mitotic cell cycle | 2.88e-02 | 1.00e+00 | 5.099 | 1 | 2 | 15 |
GO:0008135 | translation factor activity, nucleic acid binding | 2.88e-02 | 1.00e+00 | 5.099 | 1 | 4 | 15 |
GO:0000188 | inactivation of MAPK activity | 2.88e-02 | 1.00e+00 | 5.099 | 1 | 1 | 15 |
GO:0007339 | binding of sperm to zona pellucida | 2.88e-02 | 1.00e+00 | 5.099 | 1 | 4 | 15 |
GO:0003887 | DNA-directed DNA polymerase activity | 3.07e-02 | 1.00e+00 | 5.005 | 1 | 2 | 16 |
GO:0044212 | transcription regulatory region DNA binding | 3.09e-02 | 1.00e+00 | 2.846 | 2 | 13 | 143 |
GO:0004712 | protein serine/threonine/tyrosine kinase activity | 3.26e-02 | 1.00e+00 | 4.918 | 1 | 2 | 17 |
GO:0007052 | mitotic spindle organization | 3.26e-02 | 1.00e+00 | 4.918 | 1 | 3 | 17 |
GO:0031667 | response to nutrient levels | 3.26e-02 | 1.00e+00 | 4.918 | 1 | 2 | 17 |
GO:0031047 | gene silencing by RNA | 3.45e-02 | 1.00e+00 | 4.836 | 1 | 2 | 18 |
GO:0032320 | positive regulation of Ras GTPase activity | 3.45e-02 | 1.00e+00 | 4.836 | 1 | 2 | 18 |
GO:0033574 | response to testosterone | 3.45e-02 | 1.00e+00 | 4.836 | 1 | 1 | 18 |
GO:0005739 | mitochondrion | 3.53e-02 | 1.00e+00 | 1.641 | 4 | 32 | 659 |
GO:0006306 | DNA methylation | 3.64e-02 | 1.00e+00 | 4.758 | 1 | 1 | 19 |
GO:0045840 | positive regulation of mitosis | 3.82e-02 | 1.00e+00 | 4.684 | 1 | 1 | 20 |
GO:0006913 | nucleocytoplasmic transport | 3.82e-02 | 1.00e+00 | 4.684 | 1 | 2 | 20 |
GO:0071902 | positive regulation of protein serine/threonine kinase activity | 3.82e-02 | 1.00e+00 | 4.684 | 1 | 2 | 20 |
GO:0010718 | positive regulation of epithelial to mesenchymal transition | 3.82e-02 | 1.00e+00 | 4.684 | 1 | 2 | 20 |
GO:0005720 | nuclear heterochromatin | 3.82e-02 | 1.00e+00 | 4.684 | 1 | 3 | 20 |
GO:0072686 | mitotic spindle | 3.82e-02 | 1.00e+00 | 4.684 | 1 | 2 | 20 |
GO:0071897 | DNA biosynthetic process | 3.82e-02 | 1.00e+00 | 4.684 | 1 | 2 | 20 |
GO:0034660 | ncRNA metabolic process | 3.82e-02 | 1.00e+00 | 4.684 | 1 | 1 | 20 |
GO:0031647 | regulation of protein stability | 4.01e-02 | 1.00e+00 | 4.613 | 1 | 2 | 21 |
GO:0051084 | 'de novo' posttranslational protein folding | 4.20e-02 | 1.00e+00 | 4.546 | 1 | 4 | 22 |
GO:0000387 | spliceosomal snRNP assembly | 4.20e-02 | 1.00e+00 | 4.546 | 1 | 1 | 22 |
GO:0006370 | 7-methylguanosine mRNA capping | 4.57e-02 | 1.00e+00 | 4.421 | 1 | 5 | 24 |
GO:0008180 | COP9 signalosome | 4.57e-02 | 1.00e+00 | 4.421 | 1 | 6 | 24 |
GO:0005876 | spindle microtubule | 4.57e-02 | 1.00e+00 | 4.421 | 1 | 4 | 24 |
GO:0000976 | transcription regulatory region sequence-specific DNA binding | 4.76e-02 | 1.00e+00 | 4.362 | 1 | 3 | 25 |
GO:0009267 | cellular response to starvation | 4.94e-02 | 1.00e+00 | 4.305 | 1 | 1 | 26 |
GO:0005057 | receptor signaling protein activity | 4.94e-02 | 1.00e+00 | 4.305 | 1 | 2 | 26 |
GO:0016567 | protein ubiquitination | 5.09e-02 | 1.00e+00 | 2.451 | 2 | 14 | 188 |
GO:0032091 | negative regulation of protein binding | 5.31e-02 | 1.00e+00 | 4.198 | 1 | 1 | 28 |
GO:0006418 | tRNA aminoacylation for protein translation | 5.50e-02 | 1.00e+00 | 4.147 | 1 | 4 | 29 |
GO:0042752 | regulation of circadian rhythm | 5.50e-02 | 1.00e+00 | 4.147 | 1 | 5 | 29 |
GO:0006446 | regulation of translational initiation | 5.50e-02 | 1.00e+00 | 4.147 | 1 | 2 | 29 |
GO:0006281 | DNA repair | 5.83e-02 | 1.00e+00 | 2.340 | 2 | 24 | 203 |
GO:0045111 | intermediate filament cytoskeleton | 5.87e-02 | 1.00e+00 | 4.051 | 1 | 3 | 31 |
GO:0031490 | chromatin DNA binding | 5.87e-02 | 1.00e+00 | 4.051 | 1 | 1 | 31 |
GO:0000786 | nucleosome | 6.42e-02 | 1.00e+00 | 3.918 | 1 | 2 | 34 |
GO:0007254 | JNK cascade | 6.42e-02 | 1.00e+00 | 3.918 | 1 | 1 | 34 |
GO:0050434 | positive regulation of viral transcription | 6.60e-02 | 1.00e+00 | 3.876 | 1 | 5 | 35 |
GO:0043406 | positive regulation of MAP kinase activity | 6.60e-02 | 1.00e+00 | 3.876 | 1 | 1 | 35 |
GO:0031124 | mRNA 3'-end processing | 6.60e-02 | 1.00e+00 | 3.876 | 1 | 4 | 35 |
GO:0070301 | cellular response to hydrogen peroxide | 6.60e-02 | 1.00e+00 | 3.876 | 1 | 1 | 35 |
GO:0044297 | cell body | 6.60e-02 | 1.00e+00 | 3.876 | 1 | 5 | 35 |
GO:0003743 | translation initiation factor activity | 6.97e-02 | 1.00e+00 | 3.796 | 1 | 8 | 37 |
GO:0006369 | termination of RNA polymerase II transcription | 7.15e-02 | 1.00e+00 | 3.758 | 1 | 5 | 38 |
GO:0019901 | protein kinase binding | 7.37e-02 | 1.00e+00 | 2.147 | 2 | 8 | 232 |
GO:0003684 | damaged DNA binding | 7.69e-02 | 1.00e+00 | 3.648 | 1 | 1 | 41 |
GO:0005730 | nucleolus | 7.80e-02 | 1.00e+00 | 1.078 | 5 | 74 | 1217 |
GO:0001047 | core promoter binding | 7.87e-02 | 1.00e+00 | 3.613 | 1 | 4 | 42 |
GO:0000724 | double-strand break repair via homologous recombination | 7.87e-02 | 1.00e+00 | 3.613 | 1 | 5 | 42 |
GO:0006406 | mRNA export from nucleus | 8.23e-02 | 1.00e+00 | 3.546 | 1 | 7 | 44 |
GO:0010467 | gene expression | 8.25e-02 | 1.00e+00 | 1.527 | 3 | 49 | 535 |
GO:0001570 | vasculogenesis | 8.41e-02 | 1.00e+00 | 3.514 | 1 | 2 | 45 |
GO:0009612 | response to mechanical stimulus | 8.59e-02 | 1.00e+00 | 3.482 | 1 | 2 | 46 |
GO:0000502 | proteasome complex | 8.77e-02 | 1.00e+00 | 3.451 | 1 | 3 | 47 |
GO:0001558 | regulation of cell growth | 9.12e-02 | 1.00e+00 | 3.391 | 1 | 2 | 49 |
GO:0006368 | transcription elongation from RNA polymerase II promoter | 9.66e-02 | 1.00e+00 | 3.305 | 1 | 8 | 52 |
GO:0043565 | sequence-specific DNA binding | 9.87e-02 | 1.00e+00 | 1.902 | 2 | 8 | 275 |
GO:0006338 | chromatin remodeling | 1.02e-01 | 1.00e+00 | 3.224 | 1 | 7 | 55 |
GO:0016311 | dephosphorylation | 1.02e-01 | 1.00e+00 | 3.224 | 1 | 3 | 55 |
GO:0008584 | male gonad development | 1.05e-01 | 1.00e+00 | 3.173 | 1 | 1 | 57 |
GO:0042826 | histone deacetylase binding | 1.07e-01 | 1.00e+00 | 3.147 | 1 | 5 | 58 |
GO:0000785 | chromatin | 1.09e-01 | 1.00e+00 | 3.123 | 1 | 6 | 59 |
GO:0005737 | cytoplasm | 1.12e-01 | 1.00e+00 | 0.643 | 8 | 127 | 2633 |
GO:0006464 | cellular protein modification process | 1.12e-01 | 1.00e+00 | 3.075 | 1 | 4 | 61 |
GO:0030018 | Z disc | 1.18e-01 | 1.00e+00 | 3.005 | 1 | 3 | 64 |
GO:0031145 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process | 1.19e-01 | 1.00e+00 | 2.983 | 1 | 7 | 65 |
GO:0030308 | negative regulation of cell growth | 1.28e-01 | 1.00e+00 | 2.876 | 1 | 3 | 70 |
GO:0006325 | chromatin organization | 1.28e-01 | 1.00e+00 | 2.876 | 1 | 4 | 70 |
GO:0051082 | unfolded protein binding | 1.28e-01 | 1.00e+00 | 2.876 | 1 | 5 | 70 |
GO:0001889 | liver development | 1.30e-01 | 1.00e+00 | 2.856 | 1 | 4 | 71 |
GO:0030496 | midbody | 1.33e-01 | 1.00e+00 | 2.816 | 1 | 6 | 73 |
GO:0051726 | regulation of cell cycle | 1.33e-01 | 1.00e+00 | 2.816 | 1 | 3 | 73 |
GO:0001649 | osteoblast differentiation | 1.35e-01 | 1.00e+00 | 2.796 | 1 | 5 | 74 |
GO:0015630 | microtubule cytoskeleton | 1.36e-01 | 1.00e+00 | 2.777 | 1 | 5 | 75 |
GO:0071456 | cellular response to hypoxia | 1.38e-01 | 1.00e+00 | 2.758 | 1 | 2 | 76 |
GO:0006366 | transcription from RNA polymerase II promoter | 1.41e-01 | 1.00e+00 | 1.592 | 2 | 23 | 341 |
GO:0048471 | perinuclear region of cytoplasm | 1.43e-01 | 1.00e+00 | 1.579 | 2 | 11 | 344 |
GO:0005634 | nucleus | 1.44e-01 | 1.00e+00 | 0.511 | 9 | 158 | 3246 |
GO:0005819 | spindle | 1.45e-01 | 1.00e+00 | 2.684 | 1 | 6 | 80 |
GO:0030529 | ribonucleoprotein complex | 1.48e-01 | 1.00e+00 | 2.648 | 1 | 5 | 82 |
GO:0044267 | cellular protein metabolic process | 1.48e-01 | 1.00e+00 | 1.546 | 2 | 14 | 352 |
GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay | 1.52e-01 | 1.00e+00 | 2.613 | 1 | 5 | 84 |
GO:0006355 | regulation of transcription, DNA-templated | 1.58e-01 | 1.00e+00 | 1.109 | 3 | 31 | 715 |
GO:0000209 | protein polyubiquitination | 1.65e-01 | 1.00e+00 | 2.482 | 1 | 6 | 92 |
GO:0006511 | ubiquitin-dependent protein catabolic process | 1.65e-01 | 1.00e+00 | 2.482 | 1 | 6 | 92 |
GO:0045893 | positive regulation of transcription, DNA-templated | 1.66e-01 | 1.00e+00 | 1.447 | 2 | 21 | 377 |
GO:0006260 | DNA replication | 1.68e-01 | 1.00e+00 | 2.451 | 1 | 9 | 94 |
GO:0006457 | protein folding | 1.73e-01 | 1.00e+00 | 2.406 | 1 | 5 | 97 |
GO:0006413 | translational initiation | 1.76e-01 | 1.00e+00 | 2.376 | 1 | 6 | 99 |
GO:0034641 | cellular nitrogen compound metabolic process | 1.86e-01 | 1.00e+00 | 2.291 | 1 | 5 | 105 |
GO:0046777 | protein autophosphorylation | 1.87e-01 | 1.00e+00 | 2.278 | 1 | 3 | 106 |
GO:0000790 | nuclear chromatin | 1.92e-01 | 1.00e+00 | 2.237 | 1 | 9 | 109 |
GO:0042981 | regulation of apoptotic process | 1.97e-01 | 1.00e+00 | 2.198 | 1 | 4 | 112 |
GO:0043005 | neuron projection | 1.99e-01 | 1.00e+00 | 2.185 | 1 | 6 | 113 |
GO:0000287 | magnesium ion binding | 2.02e-01 | 1.00e+00 | 2.160 | 1 | 4 | 115 |
GO:0016032 | viral process | 2.02e-01 | 1.00e+00 | 1.264 | 2 | 30 | 428 |
GO:0004672 | protein kinase activity | 2.17e-01 | 1.00e+00 | 2.040 | 1 | 5 | 125 |
GO:0000398 | mRNA splicing, via spliceosome | 2.22e-01 | 1.00e+00 | 2.005 | 1 | 15 | 128 |
GO:0031625 | ubiquitin protein ligase binding | 2.37e-01 | 1.00e+00 | 1.897 | 1 | 7 | 138 |
GO:0005524 | ATP binding | 2.48e-01 | 1.00e+00 | 0.790 | 3 | 37 | 892 |
GO:0016874 | ligase activity | 2.49e-01 | 1.00e+00 | 1.816 | 1 | 11 | 146 |
GO:0001701 | in utero embryonic development | 2.61e-01 | 1.00e+00 | 1.739 | 1 | 7 | 154 |
GO:0005874 | microtubule | 2.74e-01 | 1.00e+00 | 1.657 | 1 | 10 | 163 |
GO:0008380 | RNA splicing | 2.77e-01 | 1.00e+00 | 1.639 | 1 | 21 | 165 |
GO:0007067 | mitotic nuclear division | 2.77e-01 | 1.00e+00 | 1.639 | 1 | 9 | 165 |
GO:0003677 | DNA binding | 2.78e-01 | 1.00e+00 | 0.703 | 3 | 52 | 947 |
GO:0016071 | mRNA metabolic process | 2.84e-01 | 1.00e+00 | 1.596 | 1 | 10 | 170 |
GO:0006412 | translation | 2.95e-01 | 1.00e+00 | 1.530 | 1 | 12 | 178 |
GO:0016070 | RNA metabolic process | 3.09e-01 | 1.00e+00 | 1.451 | 1 | 10 | 188 |
GO:0005743 | mitochondrial inner membrane | 3.21e-01 | 1.00e+00 | 1.383 | 1 | 9 | 197 |
GO:0004674 | protein serine/threonine kinase activity | 3.21e-01 | 1.00e+00 | 1.383 | 1 | 8 | 197 |
GO:0035556 | intracellular signal transduction | 3.24e-01 | 1.00e+00 | 1.369 | 1 | 5 | 199 |
GO:0030154 | cell differentiation | 3.31e-01 | 1.00e+00 | 1.333 | 1 | 5 | 204 |
GO:0019899 | enzyme binding | 3.39e-01 | 1.00e+00 | 1.291 | 1 | 7 | 210 |
GO:0007165 | signal transduction | 3.41e-01 | 1.00e+00 | 0.734 | 2 | 24 | 618 |
GO:0005813 | centrosome | 3.48e-01 | 1.00e+00 | 1.244 | 1 | 10 | 217 |
GO:0006351 | transcription, DNA-templated | 3.50e-01 | 1.00e+00 | 0.519 | 3 | 47 | 1076 |
GO:0008283 | cell proliferation | 3.76e-01 | 1.00e+00 | 1.105 | 1 | 8 | 239 |
GO:0006508 | proteolysis | 4.06e-01 | 1.00e+00 | 0.961 | 1 | 11 | 264 |
GO:0046982 | protein heterodimerization activity | 4.07e-01 | 1.00e+00 | 0.956 | 1 | 11 | 265 |
GO:0008270 | zinc ion binding | 4.19e-01 | 1.00e+00 | 0.500 | 2 | 39 | 727 |
GO:0008285 | negative regulation of cell proliferation | 4.21e-01 | 1.00e+00 | 0.892 | 1 | 11 | 277 |
GO:0008284 | positive regulation of cell proliferation | 4.24e-01 | 1.00e+00 | 0.881 | 1 | 8 | 279 |
GO:0006468 | protein phosphorylation | 4.49e-01 | 1.00e+00 | 0.772 | 1 | 6 | 301 |
GO:0044822 | poly(A) RNA binding | 4.68e-01 | 1.00e+00 | 0.363 | 2 | 45 | 799 |
GO:0043066 | negative regulation of apoptotic process | 4.71e-01 | 1.00e+00 | 0.675 | 1 | 8 | 322 |
GO:0005509 | calcium ion binding | 5.02e-01 | 1.00e+00 | 0.550 | 1 | 9 | 351 |
GO:0042802 | identical protein binding | 5.05e-01 | 1.00e+00 | 0.538 | 1 | 15 | 354 |
GO:0046872 | metal ion binding | 5.55e-01 | 1.00e+00 | 0.138 | 2 | 24 | 934 |
GO:0006915 | apoptotic process | 5.59e-01 | 1.00e+00 | 0.322 | 1 | 15 | 411 |
GO:0042803 | protein homodimerization activity | 5.74e-01 | 1.00e+00 | 0.264 | 1 | 13 | 428 |
GO:0005887 | integral component of plasma membrane | 6.85e-01 | 1.00e+00 | -0.162 | 1 | 8 | 575 |
GO:0003700 | sequence-specific DNA binding transcription factor activity | 6.89e-01 | 1.00e+00 | -0.179 | 1 | 22 | 582 |
GO:0045944 | positive regulation of transcription from RNA polymerase II promoter | 7.27e-01 | 1.00e+00 | -0.325 | 1 | 29 | 644 |
GO:0044281 | small molecule metabolic process | 8.21e-01 | 1.00e+00 | -0.716 | 1 | 35 | 844 |
GO:0070062 | extracellular vesicular exosome | 8.54e-01 | 1.00e+00 | -0.675 | 2 | 51 | 1641 |
GO:0016020 | membrane | 9.19e-01 | 1.00e+00 | -1.232 | 1 | 56 | 1207 |
GO:0005886 | plasma membrane | 9.78e-01 | 1.00e+00 | -1.795 | 1 | 46 | 1784 |